Gilead wins reversal of $1.2B fine in CAR-T patent fight with Bristol Myers Alphabet's Verily, Mayo Clinic team up on decision support tech for cardiovascular care FDA greenlights first smartphone-based home COVID-19 test Pfizer, BioNTech sign on with Eurofarma of Brazil for COVID-19 vaccine production AstraZeneca, rHealth develop fingerstick test for low platelet count, a rare side effect of AZ's COVID vaccine Cigna to expand ACA exchange footprint to 3 new states, 93 counties GSK's latest meningitis B campaign taps first spokescelebrity: 'Punky Brewster,' now mom of 4 ACOs generated $4.1B in gross savings in 2020, nearly double 2019 amount Unraveling the link between migraines and protection against diabetes Trinity Health Mid-Atlantic teams with NeuroFlow to offer mental health app to workers COVID-19 tracker: FDA awards nod to first smartphone-based home test; COVAX kicks off Sinopharm, Sinovac shipments Featured Story | By Angus Liu Gilead Sciences and Bristol Myers Squibb aren’t just fighting the CAR-T war in the clinic around their efficacy but also in court over patents. The latest winner? Gilead. read more |
| |
|---|
|
| | Webinar: Removing Antibody Drug Discovery's DNA Bottleneck Tuesday, September 14 | 2pm ET / 11am PT GPCRs have proven to be one of the most challenging targets for antibody drug development. In this webinar, we describe the use of next-generation DNA synthesis tools to overcome the DNA bottleneck in antibody-based GPCR drug discovery. Learn More. |
Top Stories By Heather Landi Alphabet's Verily continues to push further into clinical care and is using its tech muscle to build advanced decision support tools for providers. Teaming up with Mayo Clinic, Verily will pull in the hospital's clinical content and apply advanced clinical analytics and user-centered design to deliver care insights with an initial focus on cardiovascular and cardiometabolic conditions. read more By Conor Hale Developed by BD in collaboration with Scanwell Health, the Veritor rapid antigen test operates similar to a home pregnancy test, at first. read more By Kevin Dunleavy Eurofarma of Brazil will perform fill-finish of the Pfizer-BioNTech COVID-19 vaccine for distribution in Latin America. The agreement will provide for the supply of more than 100 million doses annually. read more By Andrea Park The chances of developing thrombocytopenia after receiving AstraZeneca's COVID-19 vaccine may be slim, but in an apparent effort to address the issue head-on, the pharma company teamed up with rHealth to develop a diagnostic test that could measure platelet count at the point of care. read more By Paige Minemyer Cigna is planning to expand its footprint on the Affordable Care Act's exchanges into three new states and 93 new counties for the 2022 plan year, the insurer announced Thursday. read more By Beth Snyder Bulik Back to school often means meningitis awareness campaigns, but this year GlaxoSmithKline is drawing a distinction between the more common MenACWY vaccine for adolescents and the separate MenB shot for older teens in the U.S. read more By Robert King Accountable care organizations generated $4.1 billion in gross savings for Medicare in 2020, nearly double the $2.6 billion they posted in 2019, new CMS data shows. read more By Kyle LaHucik University of Tennessee researchers found that the peptides behind migraine pain can trigger insulin production in mice, and the study could lead to better methods for preventing or treating diabetes. read more By Anastassia Gliadkovskaya Independence Blue Cross Foundation is teaming up with Trinity Health Mid-Atlantic and mental health tech company NeuroFlow to support its health workers’ mental health. read more By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner The FDA has awarded its first nod for at-home COVID-19 test from BD and Scanwell Health's, which delivers results through a user's smartphone. The global vaccine sharing program COVAX will ship out its first doses of Sinopharm and Sinovac vaccines despite concerns over their effectiveness, Reuters reports. Plus more headlines. read more |
